Anja Slikkerveer

Anja Slikkerveer, MD, PhD, ERT, Astellas Pharma Europe BV - Qepler Summits And Conferences

Anja Slikkerveer, MD, PhD, ERT

Scientific Director Translational Science
Astellas Pharma Europe BV
Hague, Netherlands
Astellas Pharma EMEA

Related Sessions:

Qepler - Genotoxic Impurities in Pharmaceuticals Summit thumbnail Details

Genotoxic Impurities in
Pharmaceuticals Summit 2019

GTI strategies & new methodologies: analysis, in silico & regulations. Challenges & opportunities.
  • 11 Apr 2019
  • Berlin, DE
  • Pharma
Day 1: Thursday, 11 April 2019
CASE STUDY: ICH Q3D: elemental impurities- an insider’s perspective.
  • How did the ICH process work for this quality guideline with a large safety component?
  • How were the elements covered in the guideline selected?
  • How was relevant literature selected?
  • Do the PDE cover pediatric products?
  • Can the PDE be exceeded?
View Details
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookies Policy.